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Abstract
Background: Mouse E11.5 embryonic heart enhancers were found to exhibit exceptionally weak sequence
conservation during vertebrate evolution compared to enhancers of other developing organs. However, it is
unknown whether this phenomenon is due to elevated mutation rates, or is a consequence of natural selection.
Results: In this study, based on the aligned orthologous genomic sequences of mouse and other closely related
mammals, the substitution rates of fourfold degenerate sites or intron sequences in neighboring genes were used
as neutral references to normalize substitution rates of mouse enhancers. Subsequent comparisons indicated that
heart enhancers’ evolutionary rates were increased by natural selection. Correspondingly, the results of Fisher’s
exact tests to examine the differential enrichment of substitutions between enhancers and neutral sequences
suggest that both relaxed purifying selection and positive selection caused the rapid evolution of heart enhancers.
Analyses on recombination rates and substitution patterns indicated that GC-biased gene conversion does not
contribute to evolutionary rate variations among enhancers. In general, pleiotropic enhancers and enhancers in
proximity to weakly expressed genes, tend to evolve slowly. Although heart enhancers are less pleiotropic and are
adjacent to highly expressed genes, these biases do not account for the rapid evolution observed.
Conclusions: In combination, the results of the present study suggest that factors associated with functions or
characteristics of the tissue may exert direct and profound effects on the intensity and direction of the natural
selection applied to regulatory DNAs, such as enhancers.
Background
Evolution of gene expression may underlie the morpholo-
gical diversity of animal species [1-3]. Therefore, it is
important to understand the rules that govern the evolu-
tion of regulatory DNA sequences. Enhancers are a major
category of regulatory DNAs, and are short genomic seg-
ments that bind to regulatory proteins and increase gene
transcription [4,5]. Correspondingly, enhancers have been
shown to regulate many of the processes that affect orga-
nismal development [6,7]. To locate these important regu-
latory non-coding DNAs in the mouse (Mus musculus)
genome, several thousand mouse enhancers that function
in the embryonic heart, forebrain, midbrain, or limbs were
recently identified using a p300 ChIP-Seq approach [8-10].
Subsequent analyses showed that the evolutionary signa-
tures of the enhancers associated with different tissue
types were variable: Embryonic heart enhancers exhibited
an exceptionally low sequence conservation compared
to enhancers from other tissues [9]. Since the heart is a
highly conserved organ critical to the survival of all verte-
brate organisms, DNAs associated with the regulatory
mechanisms that control heart development were
expected to be conserved across a long phylogenetic dis-
tance [11]. Although the underlying cause for the rapid
sequence evolution observed in embryonic heart enhan-
cers remains unknown, this unexpected phenomenon has
challenged the use of sequence conservation as a criterion
for predicting functionally important non-coding DNAs
[12,13].
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There are three potential explanations for the fast evolu-
tion rate observed for heart enhancers. First, the mutation
rate of heart enhancers are elevated, similar to that of fast
evolving DNAs that reside in genomic regions prone to
replication errors [14-18]. Second, heart enhancers are
subject to a more frequent, or intense, positive selection,
similar to that of genes encoding adaptive proteins where
new mutations that develop tend to be fixed more fre-
quently [19,20]. Third, heart enhancers have evolved
under a more relaxed purifying selection, similar to that of
genes with non-essential functions that have high evolu-
tion rates relative to essential genes [21,22]. To examine if
differential frequencies/intensities in mutation rate or nat-
ural selection have led to an increased evolution of heart
enhancers, based on mouse-rat or mouse-human genomic
alignments, substitution rates of fourfold degenerate sites
(d4), or intron sites (di), of neighboring genes were used as
neutral references to normalize the substitution rate of
each enhancer. Substitution rates of mouse enhancers
from different tissues were then compared. Fisher’s exact
tests were also used to examine the differential enrichment
of substitutions between enhancers and the corresponding
neutral sequences, and these results were used to deter-
mine the strength of the purifying selection, or the fre-
quency/intensity of the positive selection, experienced by
the enhancers. We also examined the potential role for
GC-biased gene conversion events in affecting the inter-
pretation of processes that accelerate sequence substitu-
tions of heart enhancers in mammals.
Studies on protein evolution have shown that unantici-
pated confounding factors could influence the identifica-
tion and interpretation of previously reported protein
evolutionary rate determinants. For instance, gene essenti-
ality was asserted to influence bacterial protein evolution-
ary rates [23]. However, a later study found that this
phenomenon was simply due to that highly expressed
genes evolved slowly and essential genes were highly
expressed [24]. Similarly, extracellularity was suggested to
be correlated with the rate of protein evolution in yeasts
[25]. Nevertheless, this was because extracellular proteins
tend to be non-essential to the organism and non-essential
genes were less constrained evolutionarily [26]. To deter-
mine whether the rapid evolution of heart enhancers is
due to factors directly associated with functions or charac-
teristics of the embryonic tissues or organs where a DNA
performs functions (termed as “tissue factors” hereafter)
[27,28], the influence of enhancer properties and neigh-
boring genes to the evolution of these heart enhancers
were examined. We found that the evolution rates of heart
enhancers were correlated with pleiotropy (see Methods),
as well as the expression levels of neighboring genes.
Embryonic heart enhancers generally were less pleiotropic
and were in proximity of highly expressed neighboring
genes. After controlling for these biases, heart enhancers
still exhibited highest rates of evolution. The results sug-
gested that tissue factors may exert direct effects on the
intensity and direction of the natural selection on enhan-
cers. Further studies to elucidate how tissue factors specifi-
cally cause variations in selective forces on enhancers are
needed.
Methods
Enhancers of developing mouse embryonic tissues
Based on the Ensembl mouse genome assembly v59
(NCBI m37), the co-activator protein, p300, was found to
bind 2759, 2786, 3839, and 3597 enhancers in forebrain,
midbrain, limb, and heart mouse embryonic tissues (Sup-
plementary material in [9]). When enhancers with overlap-
ping coordinates were consolidated into a single enhancer
region, 11,332 non-overlapping enhancer regions were
determined. These regions were further classified into
“specific enhancers” (i.e., regions consolidated from enhan-
cers of a single embryonic tissue) (n = 10,030) and “pleio-
tropic enhancers”, the remaining set of enhancers (n =
1,302). It should be noted that, since only four tissues
from the E11.5 stage were examined in p300 ChIP-seq
experiments [9], the “specific enhancers” defined in the
present study may function in other tissues or develop-
mental stages during mouse embryogenesis. Furthermore,
the term “pleiotropic” was used to describe enhancers that
are likely to significantly affect the developmental pro-
cesses of at least two of the examined embryonic organs in
[9] when they are absent from the genome. The recombi-
nation rate of the mouse genome segment in which an
enhancer was located was obtained from the Supplemen-
tary table of [29].
Properties of the mouse genes
The coordinates of the mouse genes analyzed were
retrieved from the BioMart (http://www.biomart.org/).
For mouse genes with a null phenotype, the essentiality
of each gene was defined based on phenotypic annota-
tions of Mouse Genome Informatics 4.21 (http://www.
informatics.jax.org/), according to [30]. When premature
death or infertility were the knockout phenotype, these
genes were considered essential. All other genes with at
least one documented null phenotype were considered
non-essential. The gene expression profiles for the
mouse genes analyzed were obtained from microarray
data collected using 61 mouse tissues, including 53 adult
tissues, 3 cell lines, and 5 early embryos from E6.5 to
E10.5 [31]. Expression levels were calculated by averaging
microarray-based expression signals from all tissues
according to the previous studies [22,26].
Tests of natural selection on enhancer sequences
To study the patterns and determinants of enhancer evo-
lution rates, aligned mouse-rat (Rattus norvegicus),
Liao and Weng BMC Systems Biology 2012, 6(Suppl 2):S1
http://www.biomedcentral.com/1752-0509/6/S2/S1
Page 2 of 11
mouse-human (Homo sapiens), and mouse-rat-human
orthologous genomic regions were retrieved from
Ensembl (http://www.ensembl.org/) [32], or the UCSC
Genome Browser (http://genome.ucsc.edu) [33] (genome
versions: mouse: mm9; rat: rn4; human: hg18). Sequence
divergence was subsequently calculated, and the numbers
of substitutions were computed. Based on the genomic
alignments retrieved from the UCSC Genome Browser
(http://genome.ucsc.edu) [33], the sequence divergence
of enhancer regions (D) from mouse versus other mam-
mal sequences was calculated according to baseml of
PAML [34] using a GTR model with gamma distribution
for site heterogeneity (model = 7; ncatG = 5). Fourfold
degenerate sites and intron sequences of the nearest gene
with an ortholog in the rat or human genome were used
as neutral references to an enhancer. Since mammalian
genes are often alternatively spliced and produce multiple
transcripts [35], the coding sequence and intron
sequence of a gene were defined using the exon-intron
structure of the longest isoform annotated in Ensembl
v59, with alignments of coding sequences and intron
sequences retrieved from the UCSC Genome Browser.
Fourfold degenerate sites of mouse genes were defined
according to W-H Li [36]. When intron sequences were
used as the neutral reference, similar to R Haygood,
O Fedrigo, B Hanson, K-D Yokoyama and GA Wray [37],
the first intron was removed due to the possibility it
could contain regulatory motifs [38]. The latter criterion
resulted in that intronless genes and single-intron genes
have only the neutral reference of d4, and not di. Simi-
larly, sequence divergences between mouse and another
mammal under neutrality, d4 and di, were calculated by
baseml of PAML [34] using a GTR model with gamma
distribution for site heterogeneity (model = 7; ncatG = 5).
As indicated above, the calculation of d4 or di required
the presence of an Ensembl annotation of a mouse gene
to its one-to-one ortholog to ensure the reliability of neu-
tral estimation. The normalized enhancer sequence
divergences (D/d4 or D/di) were then used as indexes for
the relative strength of selection. Lower D/d4 or D/di
values indicated a weaker purifying selection, or a stron-
ger positive selection, had occurred for the enhancer
sequence examined [1].
According to AP Rooney and J Zhang [39], Fisher’s
exact test was used to examine the natural selection on
enhancers based on the 2x2 contingency table. The row
and column categories of the table are “the enhancer vs.
the neutral reference used” and “the number of substituted
sites vs. the number of sites with no substitution”, respec-
tively. Both fourfold degenerate sites, or intron sequences
of the neighboring gene (defined above), were used as neu-
tral references to examine the differential enrichment of
substitutions between enhancers and neutral references.
Compared to the neutral reference, significantly more
substitutions in an enhancer implied that positive selection
had occurred. Alternatively, fewer substitutions in an
enhancer suggested that purifying selection had occurred.
Otherwise, the model of neutrality cannot be rejected sta-
tistically, and the enhancer would be considered to have
evolved free from natural selection.
Results and discussion
Natural selection leads to rapid evolution of embryonic
heart enhancers
In a previous study, an analysis of conservation depth
using DNA alignments from a wide range of vertebrates
identified the rapid evolution of embryonic heart enhan-
cers [9]. In the present study, sequence divergence, D
(see Methods), was used to examine the evolution rate
of enhancers, while D/d4 or D/di (see Methods) ratios
were used to examine the presence and direction of
natural selection on non-coding sequences after the
divergence of mouse-rat (Figure 1), or mouse-human
(Additional file 1), genomes. Heart enhancers were
found to have the highest D (indicating the weakest
sequence conservation), while forebrain enhancers had
the lowest D (indicating strongest sequence conserva-
tion) (mouse-rat: Figure 1A; mouse-human: Additional
file 1A). These results are consistent with the order of
enhancer types determined by the previous analysis of
conservation depth for these tissues (Figure 1b of [9]). If
the differences in D determined for enhancers of fore-
brain, midbrain, limb and heart tissues is only due to
variations in local mutation rates, these differences
should disappear when D is normalized to neutral sub-
stitution rates (e.g., approximately by d4 or di). Based on
the analysis performed, the orders of the enhancers of four
tissue types in D/d4 (mouse-rat: Figure 1B; mouse-human:
Additional file 1B) or D/di (mouse-rat: Figure 1C; mouse-
human: Additional file 1C) followed the order shown in D,
while such an order was neither observed for d4 (mouse-
rat: Figure 1D; mouse-human: Additional file 1D) nor di
(mouse-rat: Figure 1E; mouse-human: Additional file 1E).
An estimation of mouse-rat D, D/d4, and D/di with the
inclusion of human orthologous sequence as the outgroup
in the model of baseml yielded virtually identical results
(Additional file 2). Taken together, these results clearly
indicate that natural selection, and not mutation, is
responsible for the rapid sequence divergence (e.g., large
D) associated with heart enhancers.
The higher D of heart enhancers may be due to a
more relaxed purifying selection, or to a more frequent
and stronger positive selection, that occurred during
evolution. To distinguish between these possibilities,
Fisher’s exact test [39] was used on each enhancer to
examine differences in the enrichment of substitutions
between enhancers and the neutral reference [i.e., four-
fold degenerate sites present in the neighboring gene
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(Table 1 and Additional file 3) or intron sites in the
neighboring gene (sites of the first intron were excluded,
see Methods) (Table 2 and Additional file 4)]. If the
enhancer evolved without the influence of natural selec-
tion, no significant difference in the proportion of
nucleotides that underwent substitution after mouse-rat
or mouse-human divergence between the enhancer and
the neutral reference would be observed. Otherwise,
enrichment or depletion of substitutions in the enhancer
compared to the neutral reference would suggest that
the enhancer had undergone positive selection or purify-
ing selection, respectively. To minimize the effect of
enhancer pleiotropy (see Methods, and below), only
“specific enhancers” (see Methods) with available neutral
references were used in the analysis. The sample size of
the enhancers tested for Table 2 (or Additional file 4)
was smaller than that of Table 1 (or Additional file 4)
since enhancers with a nearby gene that did not have
introns or single-exon genes were excluded due to the
lack of neutral intron sites. Analyses of both mouse-rat
alignments (Table 1, 2) and mouse-human alignments
(Additional file 3, 4) were performed. Several consistent
observations were made. First, in comparison with
enhancers of the forebrain, midbrain, and limb, a
Figure 1 Evolutionary rates of enhancers. Rates of evolution calculated for mouse enhancers of embryonic forebrain (FB), midbrain (MB), limb
(LM), and heart (HT), included D (A), normalized evolutionary rates D/d4 (B) or D/di (C), and neutral substitution rates d4 (D) or di (E). The values
of upper quartile, median, and lower quartile are indicated in each box, whereas the bars outside the box indicate semi-quartile ranges. D, D/d4,
D/di, d4 and di were computed based on mouse-rat alignments. Pairwise comparisons showing significant differences in D, D/d4, D/di, d4, or di
are connected with gray lines (Mann-Whitney U test).
Table 1 The proportions of enhancers that underwent selection based on mouse-rat alignments (neutral reference:
fourfold degenerate sites)
Total Under selectiona Positively selectedb Under selectiona/Total Positively selectedb/Under selectiona Positively selectedb/Total
HT 2554 875 360 34.25% 41.14% 14.09%
FB 1253 595 67 47.48% 11.26% 5.34%
MB 1311 521 101 39.74% 19.38% 7.70%
LB 2570 1037 212 40.35% 20.44% 8.24%
FB: forebrain; MB: midbrain; LB: limb; HT: heart.
aA significantly unequal proportion of substituted sites were observed between enhancers and the fourfold degenerate sites of the neighboring gene by Fisher’s
exact test.
bEnhancers that underwent selection and had a higher substitution rate than the fourfold degenerate sites of the neighboring gene.
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smaller proportion of heart enhancers were subject to
natural selection (see item “Under selection/Total” in
Table 1, 2 and Additional file 3, 4). These results indi-
cate that heart enhancers have undergone a more
relaxed purifying selection. Second, a larger proportion
of heart enhancers had higher substitution rates than
the neutral reference, compared to the enhancers of
other tissues (see items “Positively selected/Under selec-
tion” and “Positively selected/Total” in Table 1, 2 and
Additional file 3, 4). These results indicate that mouse
embryonic heart enhancers experienced more frequent or
more intense, positive selections during their evolution.
It is important to note that estimates of the proportion
of enhancers under selection were subject to the neutral
references used. For example, when intron sites were
served as the neutral reference, a higher proportion of
enhancers were found to undergo natural selection
(item “Under selection/Total”). In addition, “Positively
selected/Under selection” and “Positively selected/Total”
values were found to slightly differ. There are several
possible explanations for these observations. First, the
available numbers and samples of enhancers used to
generate Table 1 (or Additional file 3) and Table 2 (or
Additional file 4) varied. Second, an enhancer’s neigh-
boring gene generally had a larger number of intron
sites than fourfold degenerate sites for Fisher’s exact
tests. With an increase in neutral reference sites, a statisti-
cally significant result to reject the neutral model was
more likely to be obtained. Although our estimations of
“Under selection/Total”, “Positively selected/Under selec-
tion”, and “Positively selected/Total” values may be
affected by changes in the neutral reference used, these
changes were small, especially for results based on mouse-
human alignments (Additional file 3 and 4). In addition, it
should be noted that the present study focused on the
relative values for “Under selection/Total”, “Positively
selected/Under selection”, and “Positively selected/Total”,
not the absolute values, to compare enhancers from differ-
ent tissues. Estimations of these three indexes using
a similar approach and neutral references should be
subjected to the same biases. The consistent patterns
observed for data in Tables 1 and 2 and Additional files 3
and 4 unambiguously indicate that a higher tendency of
being targeted by relaxed purifying selection or positive
selection was associated with the more rapid evolution of
mouse embryonic heart enhancers.
GC-biased gene conversion does not explain the rapid
evolution of heart enhancers
GC-biased gene conversion can mimic positive selection
by generating similar genomic patterns, thereby confound-
ing inferences regarding the type of selection that has
occurred (reviewed in [40]). To investigate the possibility
that a GC-biased gene conversion pattern could be misin-
terpreted as a positive selection of heart enhancers, we
examined whether heart enhancers are located on geno-
mic regions with higher recombination rates (recombina-
tion involves the formation of heteroduplex DNA that
triggers gene conversion). Using the most recent recombi-
nation map of the mouse genome [29], although genomic
regions containing heart enhancers were found to have
relatively high recombination rates, these recombination
rates were not higher than those of the genomic regions
containing limb enhancers (Figure 2A) (the D, D/d4, and
D/di for heart enhancers were higher than those of limb
enhancers, see Figure 1, A-C).
Furthermore, based on alignments of mouse-rat-human
orthologous DNAs, the number of nucleotides that were
ancestrally A or T before mouse-rat divergence (human
and rat are both either A or T of the aligned site) and had
a substitution event in the mouse lineage was calculated
and defined as “Nsubstituted A/T“ for each enhancer. The
number of mouse lineage-specific substitutions from A/T
to G/C (NA/T®G/C) was also calculated for each enhancer.
If heart enhancers underwent more GC-biased gene
conversion events, they would be predicted to have a
higher NA/T®G/C to Nsubstituted A/T ratio. However, heart
enhancers were associated with a significantly lower ratio
of NA/T®G/C to Nsubstituted AT (Figure 2B) compared to the
enhancers of other tissues.
In combination, the results shown in Figure 2 indicate
that heart enhancers did not experience more GC-biased
gene conversion events over their evolution. Therefore,
mechanisms associated with GC-biased gene conversion
did not explain the rapid evolution of heart enhancers
and the selective pressure acting on them.
Table 2 The proportions of enhancers that underwent selection based on mouse-rat alignments (neutral reference:
intron sites)
Total Under selectiona Positively selectedb Under selectiona/Total Positively selectedb/Under selectiona Positively selectedb/Total
HT 2475 1222 428 49.37% 35.02% 17.29%
FB 1159 748 83 64.53% 11.09% 7.16%
MB 1218 720 147 59.11% 20.41% 12.06%
LB 2470 1449 301 58.66% 20.77% 12.18%
FB: forebrain; MB: midbrain; LB: limb; HT: heart.
aA significantly unequal proportion of substituted sites were observed between enhancers and the intron sites of the neighboring gene by Fisher’s exact test.
bEnhancers that underwent selection and had a higher substitution rate than the intron sites of the neighboring gene.
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Determinants for the evolution rate of enhancer
sequences
To understand the source of the selective forces acting
on heart enhancers, the factors potentially associated
with the evolution rate of enhancer sequences, and the
properties of heart enhancers, were investigated. Two
types of enhancer characteristics were examined: enhan-
cer pleiotropy and the properties of neighboring genes.
As mentioned in Methods, enhancer regions that only
functioned in a single tissue were defined as specific
enhancer regions, while all others were defined as pleio-
tropic enhancer regions. Initially, specific enhancer
regions were found to have a significantly higher D (P <
e-300, Mann-Whitney U test, Figure 3A) compared to
pleiotropic enhancer regions. These results indicated
that specific enhancer regions had a faster rate of
sequence evolution. Furthermore, higher D/d4 (P = 6.7e-
16, U test, Figure 3D) ratios of specific enhancer regions
suggests that the faster evolution rate observed is due to
a fixation bias, rather than a mutation bias. To avoid
redundancy, analyses based on D/di were not conducted.
Previous studies reported that pleiotropic [41], or house-
keeping protein coding genes [42], are subject to more
stringent selective constraints. Similarly, the evolution of
pleiotropic enhancer regions could be constrained by
having a role in the development of a wide range of bio-
logical systems. As a result, mutations in these enhancer
regions would have greater deleterious effects. These
hypotheses are consistent with the patterns observed in
Figure 3A and 3D.
Enhancers tend to regulate neighboring genes that are
within several kilobases [9]. Therefore, we also investi-
gated the association between the evolution rate of
enhancer regions and the properties of adjacent genes
(e.g., the closest coding gene in the mouse genome).
The median distance for adjacent genes was found to be
49.7 kb. It is important to note that the adjacent gene of
an enhancer may not be the same gene used to compute
d4 or di, since the calculation of d4 and di require the
presence of a one-to-one ortholog in another genome.
For enhancer regions with an adjacent gene that is con-
sidered to be essential, a significantly smaller D (P =
3.83e-6, U test) was observed compared to enhancer
regions adjacent to a non-essential gene (Figure 3B).
These results suggest that faster rates of evolution
occurred in the latter case. It has previously been shown
that genomic regions with high gene density have low
mutation rates [43]. Moreover, highly expressed genes,
which tend to be essential [24,44], are located in gene-
dense genomic regions [45]. Thus, we expected that
genomic regions enriched with essential genes would
have a lowered mutation rate which potentially explains
Figure 3B. As expected, a smaller D for enhancer
regions with an adjacent gene that is essential was
observed, while no significant difference in D/d4 was
observed for enhancers with an adjacent essential gene
versus a non-essential gene (P = 0.27, U test, Figure 3E).
In addition, enhancer regions with a highly expressed
adjacent gene tended to evolve faster than enhancer
Figure 2 Compared to other enhancers, heart enhancers are
not subject to more frequent GC-biased gene conversions.
Heart enhancers (A) are not preferentially localized to genomic
regions with higher recombination rates and (B) do not contain
more A/T to G/C substitutions in the mouse lineages. The values of
upper quartile, median, and lower quartile are indicated in each
box, whereas the bars outside the box indicate semi-quartile ranges.
Pairwise comparisons showing significant differences are connected
with gray lines (*0.01<P≦0.05 and ***P≦0.001 by Mann-Whitney U
test). FB, forebrain; MB, midbrain; LB, limb; HT, heart.
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regions adjacent to a weakly expressed gene (Spearman’s
rank correlation coefficient s of D vs. the expression
level of the adjacent gene = 0.040, P = 1.9e-4; Figure 3C,
for U test). A slightly more significant positive correlation
was found between D/d4 and the expression level of an
adjacent gene (Spearman’s s = 0.044, P = 9.8e-5; Figure
3F, for U test), suggesting that embryonic enhancers near
weakly expressed genes are subject to a more biased
selective force. The results remained unchanged when
gene expression levels were defined by the maximum
expression signal detected for the 61 mouse tissues ana-
lyzed (Additional file 5). However, at the present stage, it
remains unclear whether expression levels of an adjacent
gene directly, or indirectly, affect D/d4. Determining the
cause of such an effect needs future studies.
Local genomic and regulatory characteristics do not
explain the rapid evolution of heart enhancers
As described in the Introduction, studies of protein evo-
lution have shown that unanticipated confounding
Figure 3 Correlations between the evolutionary rates of mouse enhancers and enhancer properties: the tissue-specificity of the enhancers
(A, D), essentiality of the adjacent gene (B, E), and the expression level of the adjacent gene (C, F). Evolutionary rates are represented by D
(A-C) or D/d4 (D-F). Spearman’s rank correlation coefficient is (C) 0.040 (P <10
-3) and (F) 0.046 (P <10-4) for the unbinned data. The values of upper
quartile, median, and lower quartile are indicated in each box, whereas the bars outside the box indicate semi-quartile ranges. Pairwise comparisons
showing significant differences in D or D/d4 are connected with gray lines (*0.01<P≦0.05 and ***P≦0.001 by Mann-Whitney U test).
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Figure 4 Properties of heart enhancers. Heart enhancers include more specific enhancers (A) and enhancers adjacent to highly expressed
genes (B). (A) The numbers in boxes represent the number of enhancers in a group. (B) The values of upper quartile, median, and lower
quartile are indicated in each box, whereas the bars outside the box indicate semi-quartile ranges. Pairwise comparisons with significantly
different expression levels of the adjacent gene are connected with gray lines (*0.01<P≦0.05 and ***P≦0.001 by (A) × 2 test or (B) Mann-Whitney
U test). FB, forebrain; MB, midbrain; LB, limb; HT, heart.
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factors can influence the identification and the interpre-
tation of determinants for coding DNA evolutionary
rates. Therefore, variations in the evolution rates of dif-
ferent embryonic tissues can result from factors indir-
ectly related to the tissue factor. In the present study,
enhancers from the forebrain, midbrain, limb, and heart
did not only differ in the tissue types from which they
were identified, but also in several of their general prop-
erties that influenced D as well as D/d4. For embryonic
heart enhancers, they typically were not pleiotropic (Fig-
ure 4A), and they tended to be physically close to highly
expressed genes (Figure 4B). Since both tissue-specific
enhancers and enhancers near highly expressed genes
have been associated with fast evolution rates due to
natural selection (Figure 3D and 3F), these biases could
also contribute to the rapid evolution of embryonic
heart enhancers.
To determine the role of enhancer pleiotropy and
proximity to highly expressed genes, D (Figure 4A) and
D/d4 (Figure 4B) values were compared for enhancers of
the embryonic forebrain, midbrain, limbs, and heart,
after controlling for the aforementioned two biases. To
control for tissue specificity, only specific enhancers
were examined. To control for the expression level of
adjacent genes, enhancers were divided into three
groups depending on the expression level of the adja-
cent gene, < 200, 200-400, and ≥ 400. D and D/d4 were
then compared for the enhancers of the four tissues
within a given group. After such controls, embryonic
heart enhancers still had the highest D (Figure 5A) and
D/d4 (Figure 5B) values. These results suggest that the
relatively low pleiotropy of embryonic heart enhancers,
and their physical proximity to highly expressed genes,
only partially accounts for their high rate of evolution
and biases in selection.
Conclusions
The rapid evolution rates of mouse embryonic heart
enhancers can potentially be explained by elevated rates
of mutation and/or changes in the direction or intensity
of natural selection. In the present study, neutral sites of
the neighboring gene were used as references to exam-
ine mutation bias, as well as selective bias, on the evolu-
tion of enhancer sequences. Subsequent analyses
Figure 5 Pleiotropy and expression levels of adjacent genes do not explain enhancer evolutionary rate variations. Comparisons of D (A)
and D/d4 (B) for mouse forebrain (FB), midbrain (MB), limb (LM), and heart (HT) enhancers after controlling for the enhancer pleiotropy and the
expression level of adjacent genes. Only specific enhancers are included in the analysis. The values of upper quartile, median, and lower quartile
are indicated in each box, whereas the bars outside the box indicate semi-quartile ranges. Pairwise comparisons showing significant difference in
D or D/d4 are connected with gray lines (***P≦0.001 by Mann-Whitney U test).
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demonstrated that the rapid evolution of mouse E11.5
heart enhancers cannot be explained by potential con-
founding factors examined in the present study, and
therefore, may be directly associated with embryonic tis-
sue factors.
The identification and understanding of regulatory
DNAs in the mammalian genome is a major goal in the
post-genomic era. This study employed a simple, yet
effective, method to explore the role of natural selection
on the evolution of non-coding sequences. Although the
present study indicates that the rapid evolution of heart
enhancers is likely to have been the result of a selective
force associated with the type of embryonic tissue
involved, the underlying causes for the relaxed selective
constraint, or the higher frequency/intensity of positive
selection, remain to be discovered. One possible under-
lying cause for a more relaxed purifying selection on
heart enhancer is that during mouse embryogenesis,
heart development begins and finishes earlier than brain
and limb developments. If all enhancer sequences iden-
tified in [9] are functional regulatory DNA sequences at
E11.5, these enhancers are regulating late-stage heart
organogenesis but early-stage organogenesis of the brain
or limbs. Mutations resulting in abnormal organ devel-
opment at a later stage of organogenesis could bring a
milder defect than those resulting in defects occur at an
earlier stage, and therefore are more tolerable to the
organism.
Our finding that heart enhancers tend to be positively
selected is particularly intriguingly. In the future, it
would be interesting to determine whether heart enhan-
cers have been repeatedly shaped by positive selection
because they are also involved in other developmental
processes associated with morphological or physiological
diversity. With the increasing abundance of functional
genomic data and phenotypic data for mouse genes,
such investigations will be feasible when a more com-
plete set of spatial and temporal p300 ChIP-Seq data for
mouse embryos and other species becomes available.
Additional material
Additional file 1: Supplementary figure S1. Evolutionary rates of
enhancers. Rates of evolution calculated for mouse enhancers of
embryonic forebrain (FB), midbrain (MB), limb (LM), and heart (HT),
included D (A), normalized evolutionary rates D/d4 (B) or D/di (C), and
neutral substitution rates d4 (D) or di (E). The values of upper quartile,
median, and lower quartile are indicated in each box, whereas the bars
outside the box indicate semi-quartile ranges. D, D/d4, D/di, d4 and di
were computed based on mouse-human alignments. Pairwise
comparisons showing significant differences in D, D/d4, D/di, d4, or di are
connected with gray lines (Mann-Whitney U test).
Additional file 2: Supplementary figure S2. Evolutionary rates of
enhancers. Rates of evolution calculated for mouse enhancers of
embryonic forebrain (FB), midbrain (MB), limb (LM), and heart (HT),
included D (A), normalized evolutionary rates D/d4 (B) or D/di (C), and
neutral substitution rates d4 (D) or di (E). The values of upper quartile,
median, and lower quartile are indicated in each box, whereas the bars
outside the box indicate semi-quartile ranges. D, D/d4, D/di, d4 and di
were computed based on mouse-rat-human multiple alignments.
Pairwise comparisons showing significant differences in D, D/d4, D/di, d4,
or di are connected with gray lines (Mann-Whitney U test).
Additional file 3: Supplementary table S1. The proportions of
enhancers that underwent selection based on mouse-human alignments
(neutral reference: fourfold degenerate sites)
Additional file 4: Supplementary table S2. The proportions of
enhancers that underwent selection based on mouse-human alignments
(neutral reference: intron sites)
Additional file 5: Supplementary figure S3. Enhancers with a highly
expressed adjacent gene evolve more rapidly. Evolutionary rates are
represented by D (A) or D/d4 (B). Gene expression level was defined by
the maximum expression signal of the 61 mouse tissues. Spearman’s
rank correlation coefficient is (C) 0.044 (P <10-4) and (F) 0.042 (P <10-3)
for the unbinned data. The values of upper quartile, median, and lower
quartile are indicated in each box, whereas the bars outside the box
indicate semi-quartile ranges. Pairwise comparisons showing significant
differences in D or D/d4 are connected with gray lines (*0.01<P≦0.05 and
***P≦0.001 by Mann-Whitney U test).
List of abbreviations
d4: substitution rate of fourfold degenerate sites; di: substitution rate of
intron sites; D: sequence divergence of enhancer regions; FB: forebrain; MB:
midbrain; LB: limb; HT: heart.
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